Universitätsmedizin der Johannes Gutenberg-Universität

Mainz 55131

1 studies enrolling now · 2 studies all time

What they study most

Gastric / Gastroesophageal Junction Adenocarcinoma, Multiple Myeloma

Studies at this site

• Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma — Starting soon
• A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to Treatment — Running, not enrolling